REG - CVS Group plc - Exercise of SAYE Options and PDMR Dealing

CVSAnnouncement

19/01/2024 14:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240119:nRSS3447Aa&default-theme=true

RNS Number : 3447A  CVS Group plc  19 January 2024

19 January 2024

 

CVS Group Plc

("CVS" or the "Company")

Exercise of SAYE Options and PDMR Dealing

 

CVS, one of the UK's leading providers of integrated veterinary services,
announces that on 19 January 2024, options over a total of 6,126 ordinary
shares of 0.2 pence each (the "Ordinary Shares") were exercised under the CVS
Group 2020 SAYE Plan (2020/2024), at an exercise price of £10.09.

The issuance of shares in connection with the SAYE Exercise was fully
satisfied by 6,126 Ordinary Shares held by the CVS Group Employee Benefit
Trust (the "EBT"). Following the SAYE Exercise, a total of
 

645 Ordinary Shares are held by the EBT, representing approximately 0.001% of
the Company's total voting rights.

Ben Jacklin, Deputy CEO exercised options over 570 Ordinary Shares in the
Company.  The balance of the options were exercised by certain other
employees and former employees of the Company.

Following his option exercise, Ben Jacklin, along with any persons closely
associated, holds a beneficial interest in 37,284 Ordinary Shares in the
Company, representing approximately 0.052% of the total voting rights of the
Company, calculated on the same basis.

The notification below, made in accordance with the requirements of the UK
Market Abuse Regulation, provides further detail.

Contacts:

CVS Group
plc
via Camarco

Richard Fairman, CEO

Scott Morrison, Company Secretary

 

Peel Hunt LLP (Nominated Adviser &
Broker)
+44 (0)20 7418 8900

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

 

   Berenberg (Joint
Broker)
+44 (0)20 3207 7800

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

 

Camarco (Financial
PR)

Geoffrey
Pelham-Lane
                     +44 (0)7733 124 226

Ginny
Pulbrook
+44 (0)7961 315 138

 

 

 

 

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them

 

 1   Details of the person discharging managerial responsibilities / person closely
     associated
 a)  Name                                      Ben Jacklin
 2   Reason for the notification
 a)  Position/status                           Deputy CEO
 b)  Initial notification /Amendment           Initial Notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                      CVS Group plc
 b)  LEI                                       213800J41XDQ2NX48O05
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted

 a)  Description of the financial instrument, type of instrument  Ordinary shares of 0.2 pence each

     Identification code                                          GB00B2863827
 b)  Nature of the transaction                                    Exercise of options under the 2020 SAYE Plan (1 January   2024 maturity)

 c)  Price(s) and volume(s)                                       Price(s)    Volume
                                                                    £10.09    570

 

 

 

 d)  Aggregated information

     - Aggregated volume

                                                                  N/A - single transaction

     - Price
 e)  Date of the transaction                                      19 January 2024
 f)  Place of the transaction                                     Outside a trading Venue

 

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

N/A - single transaction

e)

Date of the transaction

19 January 2024

f)

Place of the transaction

Outside a trading Venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHZKLFFZFLLBBL